-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11by 陳怡君“... developed by domestic pharmaceutical companies have been launched successfully in Taiwan. This study mainly...”
Get full text
-
12by 黎西涵“...提供國際新藥開發臨床試驗案件服務,為企業策略發展基礎。 === In 2010, global pharmaceutical sales is estimated to reach 880...”
Get full text
-
13by 林玉寬“... drug developing pharmaceutical company. Through the analysis of strategic development of the past based...”
Get full text
-
14by 劉惠珍, Liu, Hui-Chen“... biotechnology firms in Taiwan is used for the analysis. The biotechnology industry is classified...”
Get full text
-
15by 李昕彥, Li, Hsin Yen“... and development (R&D) process, pharmaceutical companies are increasingly turning to develop lucrative large...”
Get full text
-
16by 鍾宜玲, Chung, Yi Ling“... pharmaceutical companies in Taiwan. The analysis is based on a multiple case study that includes surveys coupled...”
Get full text
-
17by 王東田, Wang, Tung Tien“... marketing of patients; Therefore, the target customers of the pharmaceutical companies marketing services...”
Get full text
-
18by 蔡宗儒“...關鍵之一。 8. 新藥研發廠商若擁有先導研發的能力,可以減短研發時程與成本。 === Most of previous the studies on pharmaceutical industry...”
Get full text
-
19by 單鴻斌, Shann, Horng Bin“... or format of profit generation. From the analysis of the primary data (from the interviews...”
Get full text
-
20by 鄭明麒, Jane, Minky“... in the Law of Pharmaceutical Affairs and the NHI Act, implication from this study could be beneficial...”
Get full text